Does digoxin use improve mortality/morbidity in patients with contemporary heart failure with reduced ejection fraction?
Patients with contemporary heart failure with reduced ejection fraction (HFrEF) from the Swedish Heart Failure Registry
Digoxin
Mortality/morbiditycomposite
In contemporary HFrEF, digoxin use is associated with lower mortality/morbidity in patients with atrial fibrillation, but higher mortality/morbidity in those without atrial fibrillation.
The great majority of digoxin users had a history of AF. Digoxin use was associated with lower mortality/morbidity in patients with AF, but with higher mortality/morbidity in patients without AF.
Building similarity graph...
Analyzing shared references across papers
Loading...
Chris J. Kapelios
Lars H. Lund
Lina Benson
European Heart Journal - Cardiovascular Pharmacotherapy
Karolinska Institutet
University of London
University of Tennessee at Knoxville
Building similarity graph...
Analyzing shared references across papers
Loading...
Kapelios et al. (Wed,) studied this question.
www.synapsesocial.com/papers/69d575155f8349d3f7ad4f96 — DOI: https://doi.org/10.1093/ehjcvp/pvab079
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: